Section 1 - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2001) - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2001)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 1 of 2001

I, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

This Declaration commences on 1 February 2001.
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Desipramine Hydrochloride

Ferrous Sulfate – Dried

Medrysone

Prednisolone Acetate

Dated this 4th day of January 2001.

ALAN WILLIAM STEVENS

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Aged Care

Delegate of the Minister for Health and Aged Care

1National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 1 of 2001)

Get a plain-English read of 1